What question did this study set out to answer?

The aim is to provide an integrated overview of recent advances in SIRT2-targeted therapeutics and structural biology.

Advances in SIRT2‐Targeted Therapeutics: Structural Insights, Chemical Strategies, and Degrader Technologies

View Full Paper

Ask AI

Bookmark

Authors

This review demonstrates advances in SIRT2-targeted therapeutics, detailing structural insights and implications for drug development.

The aim is to provide an integrated overview of recent advances in SIRT2-targeted therapeutics and structural biology.
Overview of SIRT2's structural biology, including the catalytic core and substrate-binding channel.
Summary of medicinal chemistry advances in SIRT2 inhibitors and targeted protein degradation strategies.
Discussion of drug repurposing and computational screening for SIRT2 modulators.
Identified significant scaffolds and determinants of potency for SIRT2 inhibitors.
Outlined advantages of protein degradation strategies over traditional inhibitors.
Highlighted challenges in selectivity and pharmacokinetics for developing SIRT2-targeted therapies.

Al-Karmalawy et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark